258 related articles for article (PubMed ID: 9366669)
1. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.
Saornil MA; Fisher MR; Campbell RJ; Robertson DM; Earle JD; Eagle RC; Shields JA; Shields CL; Chandra SR; Albert DM
Arch Ophthalmol; 1997 Nov; 115(11):1395-400. PubMed ID: 9366669
[TBL] [Abstract][Full Text] [Related]
2. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study.
Avery RB; Diener-West M; Reynolds SM; Grossniklaus HE; Green WR; Albert DM
Arch Ophthalmol; 2008 Feb; 126(2):207-12. PubMed ID: 18268211
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaques.
Schilling H; Bornfeld N; Friedrichs W; Pauleikhoff D; Sauerwein W; Wessing A
Ger J Ophthalmol; 1994 Aug; 3(4-5):232-8. PubMed ID: 7804109
[TBL] [Abstract][Full Text] [Related]
5. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
[TBL] [Abstract][Full Text] [Related]
6. Early-onset scleral necrosis after iodine I 125 plaque radiotherapy for ciliochoroidal melanoma.
Corrêa ZM; Augsburger JJ; Freire J; Eagle RC
Arch Ophthalmol; 1999 Feb; 117(2):259-61. PubMed ID: 10037576
[TBL] [Abstract][Full Text] [Related]
7. NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
McCannel TA; Kim E; Kamrava M; Lamb J; Caprioli J; Yang D; McCannel CA
Retina; 2018 Dec; 38(12):2415-2421. PubMed ID: 29016456
[TBL] [Abstract][Full Text] [Related]
8. Rhegmatogenous retinal detachment in eyes with uveal melanoma.
Haimovici R; Mukai S; Schachat AP; Haynie GD; Thomas MA; Meredith TA; Gragoudas ES
Retina; 1996; 16(6):488-96. PubMed ID: 9002131
[TBL] [Abstract][Full Text] [Related]
9. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
[TBL] [Abstract][Full Text] [Related]
10. The time course of irradiation changes in proton beam-treated uveal melanomas.
Gragoudas ES; Egan KM; Saornil MA; Walsh SM; Albert DM; Seddon JM
Ophthalmology; 1993 Oct; 100(10):1555-9; discussion 1560. PubMed ID: 8414415
[TBL] [Abstract][Full Text] [Related]
11. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic changes following irradiation for uveal tract melanoma.
Petrovich Z; McDonnell JM; Palmer D; Langholz BM; Liggett PE
Am J Clin Oncol; 1994 Aug; 17(4):298-306. PubMed ID: 8048391
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
14. Monthly intravitreal bevacizumab for macular edema after iodine-125 plaque radiotherapy of uveal melanoma.
Mashayekhi A; Rojanaporn D; Al-Dahmash S; Shields CL; Shields JA
Eur J Ophthalmol; 2014; 24(2):228-34. PubMed ID: 23934823
[TBL] [Abstract][Full Text] [Related]
15. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma.
Messmer E; Bornfeld N; Foerster M; Schilling H; Wessing A
Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):391-6. PubMed ID: 1505775
[TBL] [Abstract][Full Text] [Related]
17. Complications after proton beam therapy for uveal malignant melanoma. A clinical and histopathologic study of five cases.
Kincaid MC; Folberg R; Torczynski E; Zakov ZN; Shore JW; Liu SJ; Planchard TA; Weingeist TA
Ophthalmology; 1988 Jul; 95(7):982-91. PubMed ID: 2845323
[TBL] [Abstract][Full Text] [Related]
18. Histopathology of proton beam-irradiated vs enucleated uveal melanomas.
Saornil MA; Egan KM; Gragoudas ES; Seddon JM; Walsh SM; Albert DM
Arch Ophthalmol; 1992 Aug; 110(8):1112-8. PubMed ID: 1323252
[TBL] [Abstract][Full Text] [Related]
19. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
[TBL] [Abstract][Full Text] [Related]
20. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial.
Char DH; Quivey JM; Castro JR; Kroll S; Phillips T
Ophthalmology; 1993 Oct; 100(10):1547-54. PubMed ID: 8414414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
